MoneyWorks4Me

Morepen Laboratories reports Profit after tax of Rs 251.43 Mln, in the March 2021 quarter

04 May 2021 Evaluate
The Sales for the quarter ended March 2021 of Rs. 2641.05 millions rose by 39.63% from Rs. 1891.51 millions.The company almost doubled its revenue to Rs. 251.43 millions  from Rs. 94.78 millions in the quarter ended March 2021.Operating Profit saw a handsome growth to 315.20 millions from 180.69 millions in the quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 2641.05 1891.51 39.63 11124.22 7919.87 40.46 7919.87 7172.43 10.42
Other Income 38.68 17.22 124.62 117.73 94.17 25.02 94.17 36.72 156.45
PBIDT 315.20 180.69 74.44 1241.43 738.83 68.03 738.82 686.93 7.55
Interest -0.54 6.20 -108.71 17.88 19.67 -9.10 19.68 20.71 -4.97
PBDT 315.74 174.49 80.95 1223.55 719.16 70.14 719.14 666.22 7.94
Depreciation 64.31 79.71 -19.32 281.10 344.33 -18.36 344.34 380.08 -9.40
PBT 251.43 94.78 165.28 942.45 374.83 151.43 374.80 286.14 30.98
TAX 0.00 0.00 0.00 0.00 51.49 0.00 51.49 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 251.43 94.78 165.28 942.45 323.34 191.47 323.31 286.14 12.99
Equity 899.59 899.59 0.00 899.59 899.59 0.00 899.59 899.59 0.00
PBIDTM(%) 11.93 9.55 24.93 11.16 9.33 19.63 9.33 9.58 -2.60
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..